Pharmaceutical Product Development Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Pharmaceutical Product Development and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 18500 Pharmaceutical Product Development employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Pharmaceutical Product Development has purchased the following applications: Zoominfo Platform for Account Based Marketing in 2023, Lumen Cloud (ex CenturyLink) for Application Hosting and Computing Services in 2018, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Pharmaceutical Product Development is running and its propensity to invest more and deepen its relationship with Zoominfo , Lumen Technologies , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Pharmaceutical Product Development revenues, which have grown to $15.00 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Pharmaceutical Product Development intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.